A retrospective examination of 36 BD patients treated with ANA or CAN, conducted by Fabiani et al., revealed that IL-1 blockade demonstrated favorable therapeutic efficacy in BU and BD patients with extended disease duration. This evidence concerns the gene IL1B and Crouzon syndrome-acanthosis nigricans syndrome.